Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

33.87

-0.17 (-0.50%)

At close: Mar 6, 2026, 4:00 PM EST

34.54

+0.67 (1.98%)

After-hours: Mar 6, 2026, 7:52 PM EST

Corcept Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	120.5	127.67	135.55	66.33	77.62
Short-Term Investments	251.66	255.67	232.67	365.34	145.92
Cash & Short-Term Investments	372.15	383.33	368.22	431.67	223.54
Cash Growth	-2.92%	4.10%	-14.70%	93.11%	-49.28%
Accounts Receivable	59.79	53.98	41.12	31.06	27.63
Other Receivables	-	-	14	14	-
Total Trade Receivables	59.79	53.98	55.12	45.06	27.63
Inventory	12.87	12.41	7.73	6.1	4.99
Other Current Assets	40.66	21.88	27.56	16.42	10.32
Total Current Assets	485.46	471.6	458.64	499.25	266.46
Net Property, Plant & Equipment	6.47	8.01	0.32	1.78	1.52
Long-Term Investments	160.27	219.83	57.18	4.95	112.28
Other Long-Term Assets	184.44	141.11	105.39	77.45	43.5
Total Assets	836.65	840.55	621.52	583.43	423.76
Accounts Payable	40.44	15.38	17.4	11.98	6.91
Accrued Expenses	124.56	124.57	86.96	59.37	40.11
Current Portion of Leases	1.08	0.83	0.15	1.14	0.53
Total Current Liabilities	166.09	140.77	104.51	72.49	47.54
Long-Term Leases	5.02	6.11	-	-	-
Other Long-Term Liabilities	17.74	14.08	10.31	9.1	0.41
Total Long-Term Liabilities	22.76	20.19	10.31	9.1	0.41
Total Liabilities	188.85	160.96	114.81	81.59	47.95
Common Stock	0.14	0.14	0.13	0.13	0.13
Treasury Stock	-966.59	-696.17	-635.08	-456.15	-410.41
Additional Paid-in Capital	968.6	832.11	738.52	662.34	591.35
Accumulated Other Comprehensive Income	2.26	-0.22	0.61	-0.87	-0.23
Retained Earnings	643.39	543.74	402.53	296.39	194.97
Shareholders' Equity	647.81	679.59	506.71	501.84	375.81
Total Liabilities & Equity	836.65	840.55	621.52	583.43	423.76
Total Debt	6.11	6.94	0.15	1.14	0.53
Net Cash (Debt)	366.05	376.4	368.07	430.53	223.01
Net Cash Growth	-2.75%	2.26%	-14.51%	93.05%	-49.10%
Net Cash Per Share	3.05	3.32	3.29	3.71	1.77
Book Value	647.81	679.59	506.71	501.84	375.81
Book Value Per Share	5.40	5.99	4.53	4.33	2.98
Tangible Book Value	647.81	679.59	506.71	501.84	375.81
Tangible Book Value Per Share	5.40	5.99	4.53	4.33	2.98

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q